Lee, Cerina
Lin, Mu
Martins, Karen J. B.
Dyck, Jason R. B.
Klarenbach, Scott
Richer, Lawrence
Jess, Ed
Hanlon, John G.
Hyshka, Elaine
Eurich, Dean T.
Article History
Received: 1 February 2021
Accepted: 15 April 2021
First Online: 1 May 2021
Declarations
:
: This study was approved by the University of Alberta Health Research Ethics board (PRO 00084689).Patients and the public were not involved in the design, conduct and reporting of this research project as it was not applicable to this project.
: Not applicable.
: JRBD was a former member of the board of directors for Aurora Cannabis Inc., which is a for-profit, company licensed for the cultivation and sale of medical cannabis. In the past, JGH has worked as a paid advisor and speaker for Canadian Cannabis Clinics- however, currently has no clinical or financial ties. JRBD currently has financial interest in Aurora Cannabis Inc. DTE and JRBD heldĀ a Mitacs Grant with Aurora as a partner. Mitacs is a national, not-for-profit organization that works with universities, private companies, and both federal and provincial governments, to build partnerships and administer research funding that supports industrial and social innovation in Canada. DTE does not have any past or present financial interest in the companies involved. All other authors have no conflicts of interest to declare. Moreover, the research funders and companies listed were not involved in any aspect of the design or write-up of the study and all analysis was performed independent from the funders and companies.